481 related articles for article (PubMed ID: 23649748)
21. Traditional biomarkers in narcolepsy: experience of a Brazilian sleep centre.
Coelho FM; Pradella-Hallinan M; Pedrazzoli M; Soares CA; Fernandes GB; Gonçalves AL; Tufik S; Bittencourt LR
Arq Neuropsiquiatr; 2010 Oct; 68(5):712-5. PubMed ID: 21049180
[TBL] [Abstract][Full Text] [Related]
22. Presentations of primary hypersomnia in Chinese children.
Han F; Lin L; Li J; Aran A; Dong SX; An P; Zhao L; Li M; Li QY; Yan H; Wang JS; Gao HY; Li M; Gao ZC; Strohl KP; Mignot E
Sleep; 2011 May; 34(5):627-32. PubMed ID: 21532956
[TBL] [Abstract][Full Text] [Related]
23. Sleep transitions in hypocretin-deficient narcolepsy.
Sorensen GL; Knudsen S; Jennum P
Sleep; 2013 Aug; 36(8):1173-7. PubMed ID: 23904677
[TBL] [Abstract][Full Text] [Related]
24. [Narcolepsy: etiology, clinical features, diagnosis and treatment].
Zawilska JB; Woldan-Tambor A; Płocka A; Kużajska K; Wojcieszak J
Postepy Hig Med Dosw (Online); 2012 Oct; 66():771-86. PubMed ID: 23175331
[TBL] [Abstract][Full Text] [Related]
25. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
26. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
Heier MS; Evsiukova T; Vilming S; Gjerstad MD; Schrader H; Gautvik K
Sleep; 2007 Aug; 30(8):969-73. PubMed ID: 17702265
[TBL] [Abstract][Full Text] [Related]
27. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.
Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L
Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981
[TBL] [Abstract][Full Text] [Related]
28. Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1.
van der Hoeven AE; Fronczek R; Schinkelshoek MS; Roelandse FWC; Bakker JA; Overeem S; Bijlenga D; Lammers GJ
Sleep; 2022 May; 45(5):. PubMed ID: 35554594
[TBL] [Abstract][Full Text] [Related]
29. Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1.
Pizza F; Barateau L; Jaussent I; Vandi S; Antelmi E; Mignot E; Dauvilliers Y; Plazzi G;
Neurology; 2019 Sep; 93(11):e1034-e1044. PubMed ID: 31405906
[TBL] [Abstract][Full Text] [Related]
30. What Does One Sleep-Onset REM Period—During Either Nocturnal Polysomnography or Multiple Sleep Latency Test—Mean in Differential Diagnosis of Central Hypersomnias?
Bozluolcay M; Nalbantoglu M; Benbir Senel G; Karadeniz D
J Clin Neurophysiol; 2015 Aug; 32(4):364-8. PubMed ID: 26241245
[TBL] [Abstract][Full Text] [Related]
31. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
Khatami R; Maret S; Werth E; Rétey J; Schmid D; Maly F; Tafti M; Bassetti CL
Lancet; 2004 Apr; 363(9416):1199-200. PubMed ID: 15081654
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
Heier MS; Jansson TS; Gautvik KM
J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
[TBL] [Abstract][Full Text] [Related]
33. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.
Vankova J; Stepanova I; Jech R; Elleder M; Ling L; Mignot E; Nishino S; Nevsimalova S
Sleep; 2003 Jun; 26(4):427-30. PubMed ID: 12841368
[TBL] [Abstract][Full Text] [Related]
34. Narcolepsy in the older adult: epidemiology, diagnosis and management.
Chakravorty SS; Rye DB
Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
[TBL] [Abstract][Full Text] [Related]
35. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
[TBL] [Abstract][Full Text] [Related]
36. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
[TBL] [Abstract][Full Text] [Related]
37. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.
Ruoff C; Rye D
Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185
[TBL] [Abstract][Full Text] [Related]
38. HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy.
Hayduk R; Flodman P; Spence MA; Erman MK; Mitler MM
Sleep; 1997 Oct; 20(10):850-7. PubMed ID: 9415944
[TBL] [Abstract][Full Text] [Related]
39. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
40. Hypocretin and human African trypanosomiasis.
Dauvilliers Y; Bisser S; Chapotot F; Vatunga G; Cespuglio R; Josenando T; Buguet A
Sleep; 2008 Mar; 31(3):348-54. PubMed ID: 18363311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
